SARS-CoV-2 (B.1.1.7) Inhibitor Screening Kit (Spike RBD)

Multiple variants of SARS-CoV-2 are circulating globally and posting new challenges to human health. As concerns over the potential impacts of the variants grow, the deleloped of effcient treatment agaginst multiple variants of SARS-CoV-2 is an emergent need for global pubic heath.It is necessary to develop SARS-CoV-2 inhibitors, such as vaccines，therapeutic antibodies and small molecule compounds against SARS-CoV-2(B.1.1.7). Therefore, it is helpful to develop the SARS-CoV-2 (B.1.1.7) Inhibitor Screening Kit (Spike RBD) to test SARS-CoV-2 inhibitors.